<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by MGC Pharmaceuticals on Medium]]></title>
        <description><![CDATA[Stories by MGC Pharmaceuticals on Medium]]></description>
        <link>https://medium.com/@mgcpharma?source=rss-63fa79355757------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*e4WEniNi3SPZDOJQoGDT3g.png</url>
            <title>Stories by MGC Pharmaceuticals on Medium</title>
            <link>https://medium.com/@mgcpharma?source=rss-63fa79355757------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Wed, 18 Nov 2026 11:43:11 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@mgcpharma/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[The new MGC Pharma Website]]></title>
            <link>https://medium.com/mgc-pharmaceuticals/the-new-mgc-pharma-website-5db7d607fc7d?source=rss-63fa79355757------2</link>
            <guid isPermaLink="false">https://medium.com/p/5db7d607fc7d</guid>
            <category><![CDATA[cannabis-medical]]></category>
            <category><![CDATA[cannabis-journalism]]></category>
            <category><![CDATA[medical-marijuana]]></category>
            <category><![CDATA[cannabis]]></category>
            <category><![CDATA[cannabidiol]]></category>
            <dc:creator><![CDATA[MGC Pharmaceuticals]]></dc:creator>
            <pubDate>Thu, 26 Oct 2017 08:01:09 GMT</pubDate>
            <atom:updated>2017-11-16T22:53:29.848Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*50Q3jsqB_TyXh4sG10gx7w.png" /></figure><p><em>A word from Ron Lipsky, Manager of Business Development and International Relations</em></p><p>It brings me great pleasure to announce the new MGC Pharma website, which went live on the 24th of October. We’ve been working hard for the past few months on completely reworking our website to bring to life our new design that offers unique, user-friendly experiences to each of MGC Pharma’s three main audiences: doctors, patients and investors.</p><p>Users can easily select the user experience they want (Investors, Doctors or Patients) and be linked to information and updates specific to them. Doctors receive medical updates. Investors receive financial and company updates and patients receive general information about Medical Cannabis and how they can access it.</p><p>Investors will be taken to the Investor Centre, a section dedicated to the latest information about MGC Pharma, including ASX announcements, financial reports, and other important updates. Investors can also access FAQs and view the latest share price information.</p><p>Doctors will be led to the Doctor access point, where they can learn more about Medical Cannabis and engage with MGC Pharma to learn how to become an authorised prescriber in certain countries. They can also discover the Research &amp; Development going on at MGC Pharma to assist them in understanding the changes that will be coming with the inclusion of Phytocannabinoid medications within the existing treatment spectrum.</p><p>Patients will be directed to the Patient portal, which will give them general information about Medical Cannabis, how they can access it and any other information that could be beneficial towards them. MGC Pharma also collects non-confidential patient information here, for future clinical trials and patient outreach. We strive to help everyone discover the unexplored avenues of Medical Cannabis and find the proven solutions that they have been looking for.</p><p>We’ve also updated all the copy on the website, providing updates on the company history, who we are, what we do, where we are and why people should invest in our ever expanding company.</p><p>We are very excited about our new website and how it will change the way different visitors experience and interact with MGC Pharma. We are very pleased to share our new website with you and hope it will help with our vision to create a better overall understanding of how beneficial Medical Cannabis can be in treating various diseases.</p><p>See it for yourself <a href="https://mgcpharma.com.au/">here</a>.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*ktCb6mShWVUEquHzEviSIw.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*-MJCLABNm3I66gbakc3z8A.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*98Vrd1ILAcg3gWmXyXkQvg.png" /></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=5db7d607fc7d" width="1" height="1" alt=""><hr><p><a href="https://medium.com/mgc-pharmaceuticals/the-new-mgc-pharma-website-5db7d607fc7d">The new MGC Pharma Website</a> was originally published in <a href="https://medium.com/mgc-pharmaceuticals">MGC Pharmaceuticals</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[A Brief History of Medical Cannabis]]></title>
            <link>https://medium.com/mgc-pharmaceuticals/a-brief-history-of-medical-cannabis-7deab2105013?source=rss-63fa79355757------2</link>
            <guid isPermaLink="false">https://medium.com/p/7deab2105013</guid>
            <category><![CDATA[cannabidiol]]></category>
            <category><![CDATA[medical-marijuana-news]]></category>
            <category><![CDATA[cannabis]]></category>
            <category><![CDATA[medical-marijuana]]></category>
            <category><![CDATA[cannabis-medical]]></category>
            <dc:creator><![CDATA[MGC Pharmaceuticals]]></dc:creator>
            <pubDate>Thu, 05 Oct 2017 08:17:09 GMT</pubDate>
            <atom:updated>2017-10-05T08:17:09.308Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*ImomluaUiwwpe4JlvZT_Iw.jpeg" /><figcaption>A picture from the MGC Pharmaceuticals farm.</figcaption></figure><p>In modern society, Medical Cannabis is just starting to receive the recognition it deserves when it comes to treating diseases such as Epilepsy.</p><p>But Medical Cannabis actually has a long and storied history, dating back thousands of years. In this blog, we will examine the history of Medical Cannabis and how it has been used over time.</p><p>The use of Medical Cannabis can be traced back as early as 2737 B.C. Chinese legend states that the Emperor, Shen Neng, prescribed Cannabis to treat a variety of ailments including gout, rheumatism, malaria and poor memory.</p><p>Between 2000–1400 B.C. India also remained very closely tied to Cannabis for medical purposes, creating drinks to treat all types of diseases. One of the most popular of these drinks was ‘bhang’ made from Cannabis paste, milk, ghee and spices. This drink was said to release people from anxiety and is still available in certain areas of India to this day.</p><p>In Ancient Egypt, Cannabis was used medically to treat inflammation. This was noted as early as 1550 B.C. in Ebers Papyrus.</p><p>In 200 A.D. Chinese Surgeon, Hua Tuo was the first ever recorded physician to use Medical Cannabis as an anesthetic during surgery. In fact, the Chinese word for ‘anesthesia is ‘<em>mázui</em>’, which literally translates to “Cannabis intoxication.” During this time, it was also used to treat blood clots, tapeworms, constipation and hair loss.</p><p>In Europe during the Middle Ages (100–1000s A.D.) Cannabis was still used as folk medicine to treat tumours, cough and jaundice.</p><p>In the late 1700s, American medical journalists suggested that Cannabis could treat various health problems including skin inflammation, incontinence, rheumatism and nausea.</p><p>In 1937, the Marijuana Tax Act was passed in the US, declaring all non-medical Cannabis illegal. At the time, Medical Cannabis was still being used to treat a number of medical conditions.</p><p>In 1970, Cannabis was categorized as a Schedule I drug, comparing it to other, more dangerous drugs.</p><p>Since then, it was a long period of time before Medical Cannabis could be used legally. California legalised the use of Medical Cannabis in 1996, and so far, 28 other States in the US have now legalised it as well.</p><p>Back home in Australia, the use of Medical Cannabis was only legalised in February of 2016. Since then, many scientists have been hard at work, researching Medical Cannabis and what it can do to treat illnesses. Already, we’ve seen how effective it is<a href="http://www.nejm.org/doi/full/10.1056/NEJMoa1611618?query=featured_home"> treating epilepsy</a>, with more research being done by MGC Pharma’s own Dr Neubauer, available <a href="http://www.asx.com.au/asxpdf/20170214/pdf/43fzp0bfcwxt0v.pdf">here</a>. and research is well under way at RMIT, in collaboration with MGC Pharma to determine whether it is effective in treating Melanoma Cancer, which you can see<a href="https://www.youtube.com/playlist?list=PLcq70SKmNbOImUdqNPC6N-RI_CGjWOr3V"> here</a>.</p><p>After a long period of time where it was illegal to treat illnesses with Medical Cannabis, only now are we beginning to again see the medical benefits of this plant.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=7deab2105013" width="1" height="1" alt=""><hr><p><a href="https://medium.com/mgc-pharmaceuticals/a-brief-history-of-medical-cannabis-7deab2105013">A Brief History of Medical Cannabis</a> was originally published in <a href="https://medium.com/mgc-pharmaceuticals">MGC Pharmaceuticals</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Announcing our Medical Cannabis research collaboration with RMIT University]]></title>
            <link>https://medium.com/mgc-pharmaceuticals/announcing-our-medical-cannabis-research-collaboration-with-rmit-c69dbe2a2538?source=rss-63fa79355757------2</link>
            <guid isPermaLink="false">https://medium.com/p/c69dbe2a2538</guid>
            <category><![CDATA[cannabis]]></category>
            <category><![CDATA[medical-marijuana]]></category>
            <category><![CDATA[cannabis-journalism]]></category>
            <category><![CDATA[cannabis-medical]]></category>
            <dc:creator><![CDATA[MGC Pharmaceuticals]]></dc:creator>
            <pubDate>Mon, 18 Sep 2017 11:29:51 GMT</pubDate>
            <atom:updated>2017-09-18T11:50:43.593Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*a02HagX8oyu6JDve5VRTqA.jpeg" /></figure><h4>A step forward in Cannabis research.</h4><p>We are excited to announce that MGC Pharmaceuticals has partnered with RMIT University to work exclusively on several research projects. This collaboration will put us at the forefront of Australian, and global Cannabis research.</p><p>RMIT University has a rich history of evidence-based research on traditional medicine. MGC Pharma is looking forward to seeing the research that comes out of their institution in the future, relating to Medical Cannabis and its uses.</p><p>The collaboration involves two key projects that will be the first of their kind in Australia, delivering significant benefits to the Medical Cannabis Industry.</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2Fvideoseries%3Flist%3DPLcq70SKmNbOImUdqNPC6N-RI_CGjWOr3V&amp;url=http%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DfJbTu4uo-sU&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2FfJbTu4uo-sU%2Fhqdefault.jpg&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/712bc30de244916fe630073dc5ebc223/href">https://medium.com/media/712bc30de244916fe630073dc5ebc223/href</a></iframe><p>The first project will be the establishment of a world-first digital library of Cannabis medicine, known as ‘The Library’. It will encompass comprehensive information on Medical Cannabis research, including genetic information on strains, their Cannabinoid profile, and their effectiveness in treating various disorders through research and clinical data.</p><p>The Library will be made up of research done at RMIT and any future research, as well as research and data completed by global partners. Once The Library is complete, it will be used by doctors, clinicians and researchers to identify which Cannabinoid strains are effective in treating various disorders.</p><p>The second project to come out of the partnership will see RMIT investigating the positive effects of formulations derived from Medical Grade Cannabis on melanoma cancer.</p><p>For the past five years, MGC Pharma has been working with its global partners to identify effective strains of Medical Grade Cannabis. These strains will be imported to Australia and researched further to identify which strains can consistently kill melanoma cells when grown in a controlled environment.</p><p>This project is very important for MGC Pharma. This is because Australia has one of the highest rates of melanoma in the world, being the third most common cancer in the country, with almost 14,000 Australians being diagnosed in 2017.</p><p>Through the research at RMIT, we hope to find a way to better treat melanoma patients and significantly lower the amount of deaths caused by the disease each year.</p><p>It is a known fact that Australia is falling behind other developed countries in regards to providing licenses and access to Medical Cannabis. However, this is changing rapidly as more and more people look at the research both here and overseas.</p><p>Our hope is that through our collaboration with RMIT and the research that comes from it, Medical Cannabis will become more widely accepted in Australia, putting MGC Pharma on the forefront of Medical Cannabis based research.</p><p>We look forward to sharing our findings and research with you.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=c69dbe2a2538" width="1" height="1" alt=""><hr><p><a href="https://medium.com/mgc-pharmaceuticals/announcing-our-medical-cannabis-research-collaboration-with-rmit-c69dbe2a2538">Announcing our Medical Cannabis research collaboration with RMIT University</a> was originally published in <a href="https://medium.com/mgc-pharmaceuticals">MGC Pharmaceuticals</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Medical Cannabis: What the research tells us so far]]></title>
            <link>https://medium.com/mgc-pharmaceuticals/medical-cannabis-what-the-research-tells-us-so-far-9c2a66b1aeee?source=rss-63fa79355757------2</link>
            <guid isPermaLink="false">https://medium.com/p/9c2a66b1aeee</guid>
            <category><![CDATA[marijuana]]></category>
            <category><![CDATA[medical-marijuana]]></category>
            <category><![CDATA[cannabidiol]]></category>
            <category><![CDATA[cannabis-medical]]></category>
            <dc:creator><![CDATA[MGC Pharmaceuticals]]></dc:creator>
            <pubDate>Mon, 18 Sep 2017 11:27:23 GMT</pubDate>
            <atom:updated>2017-09-18T11:38:14.403Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*un9bV_SpTW5VlwMtxGhIew.jpeg" /></figure><p>I’m sure you’ve heard in the news that more and more scientific research is being done to discover the benefits of Medical Cannabis and how it can treat different diseases. While a lot of this research is still in the early stages, we have already seen significant developments, with research concluding that Medical Cannabis has proven health benefits that can be used to effectively treat diseases.</p><p>In this blog, we will examine what all the research has told us so far and what we can expect to hear from further research in the future.</p><h4><strong>1. CBD as an anti-inflammatory</strong></h4><p>Research out of the<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851925/"> University of Kentucky</a> has shown us that CBD can significantly suppress chronic inflammatory and neuropathic pain with no side effects.</p><p>Unlike opiate painkillers, which only mask pain and can potentially be very addictive with the body able to build up a tolerance over time, CBD is an effective anti-inflammatory that won’t lose effectiveness over time.</p><h4><strong>2. CBD as anxiety relief</strong></h4><p><a href="https://link.springer.com/article/10.1007/s13311-015-0387-1">Preclinical research</a> has shown that CBD can be used as a potential treatment for anxiety disorders.</p><p>So far, some of the only treatment for anxiety disorders has been dangerous anxiety medications such as Xanax and Valium, which are highly addictive.</p><p>CBD offers a natural alternative that can be just as effective, without harmful side effects.</p><p>While more research still needs to be done, it is a very exciting development that could reduce people’s dependence on dangerous anti-anxiety medication.</p><h4><strong>3. CBD as nausea relief</strong></h4><p>CBD has been touted for centuries as a potent nausea and vomiting reliever. This was confirmed by<a href="http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01621.x/full"> a study</a> published in the British Journal of Pharmacology, stating that CBD featured anti-nausea and antiemetic effects when administered.</p><h4><strong>4. CBD in the treatment of seizures</strong></h4><p>One of the biggest cases for the use of Medical Cannabis, in countries where it hasn’t yet been legalised, is its ability to treat children with epilepsy and severe seizures, where other forms of modern medicine have failed.</p><p><a href="http://www.nejm.org/doi/full/10.1056/NEJMoa1611618?query=featured_home">A recent study</a> from The New England Journal of Medicine shows us the most exciting results so far, indicating that CBD could drastically reduce seizures in children with Dravet syndrome, a potentially fatal form of epilepsy. The study showed that on average, there was a 39% decrease of seizures in children taking part in the study, with 5% of the children becoming 100% seizure-free over the course of the 14-week trial.</p><h4><strong>5. Medical Cannabis as an appetite stimulant</strong></h4><p>Cannabis is well known for being a powerful appetite stimulant in both healthy and sick individuals.</p><p>Recent studies available<a href="http://onlinelibrary.wiley.com/doi/10.1002/eat.22173/abstract"> here</a> and<a href="https://www.ncbi.nlm.nih.gov/pubmed/27503475"> here</a>, suggest that Medical Cannabis can also be used to boost the appetite and increase weight gain in patients with cancer, anorexia and HIV-associated wasting syndrome.</p><h4><strong>6. Medical Cannabis as a potential treatment for cancer</strong></h4><p>There’s<a href="http://wakingtimesmedia.com/20-medical-studies-show-cannabis-can-potentially-cure-cancer/"> a lot of research</a> that indicates that Medical Cannabis can potentially treat various forms of cancer.</p><p>MGC Pharmaceuticals has recently partnered with RMIT to conduct our own research of Medical Cannabis being used to treat Melanoma, which you can learn more about<a href="https://www.youtube.com/playlist?list=PLcq70SKmNbOImUdqNPC6N-RI_CGjWOr3V"> here</a>.</p><p>A lot more research still needs to be done before anything is conclusive, but we are very excited about the potential that Medical Cannabis has in the treatment of different forms of cancer.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=9c2a66b1aeee" width="1" height="1" alt=""><hr><p><a href="https://medium.com/mgc-pharmaceuticals/medical-cannabis-what-the-research-tells-us-so-far-9c2a66b1aeee">Medical Cannabis: What the research tells us so far</a> was originally published in <a href="https://medium.com/mgc-pharmaceuticals">MGC Pharmaceuticals</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[4 reasons why now is the perfect time to invest in the Medical Cannabis Market]]></title>
            <link>https://medium.com/mgc-pharmaceuticals/4-reasons-why-now-is-the-perfect-time-to-invest-in-the-medical-cannabis-market-f0ca94ac479c?source=rss-63fa79355757------2</link>
            <guid isPermaLink="false">https://medium.com/p/f0ca94ac479c</guid>
            <category><![CDATA[cannabis]]></category>
            <category><![CDATA[cannabidiol]]></category>
            <category><![CDATA[cannabis-medical]]></category>
            <category><![CDATA[medical-marijuana]]></category>
            <dc:creator><![CDATA[MGC Pharmaceuticals]]></dc:creator>
            <pubDate>Mon, 18 Sep 2017 11:26:19 GMT</pubDate>
            <atom:updated>2017-09-18T11:42:31.011Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*Fj4cyfUuonr0bqRHDdiPWQ.jpeg" /></figure><p>With recent <a href="http://www.aph.gov.au/Parliamentary_Business/Bills_Legislation/Bills_Search_Results/Result?bId=r5609">reforms</a> happening in Australia allowing the use of Medical Cannabis for medicinal purposes, there is widespread excitement and enthusiasm for investment in the Medical Cannabis market.</p><p>With companies regularly entering the Medical Cannabis industry in Australia, it would be fair to wonder why there is so much interest in the market, and whether or not to invest.</p><p>Here are 4 reasons why you should look into investing in the Medical Cannabis market:</p><h4><strong>1. The research speaks for itself</strong></h4><p>The medical and wider community are just beginning to understand what Medical Cannabis can do. New research is being undertaken, to prove the benefits of Medical Cannabis. Early findings have suggested that it can effectively treat chronic pain, chemotherapy induced nausea, symptoms of multiple sclerosis (MS), epilepsy and post-traumatic stress disorder (PTSD).</p><p>MGC Pharmaceuticals has also just begun <a href="https://www.youtube.com/watch?v=GshgA9IqtkI">ground-breaking new research</a>, collaborating with <a href="https://www.rmit.edu.au/research">RMIT University</a> to uncover how Medical Cannabis can treat Melanoma cancer.</p><p>While the world is still in the early stages of understanding what Medical Cannabis can do, the early results are overwhelmingly positive. We believe this will lead to increased demand for an already booming market.</p><h4><strong>2. Sales of Medical Cannabis are on the rise</strong></h4><p><a href="http://yahoonewsdigest-us.tumblr.com/post/159765066134/budding-business-americans-drawn-to-weeds-market">Recent research into Medical Cannabis sales</a> by Marijuana investment group, Arcview, showed that last year Medical Cannabis sales hit $US6.7 billion in the United States alone. That equates to roughly $8.25 billion AUD. The report also predicted that this number will grow to $US21 billion by 2021 (roughly $26 billion AUD). We hope to see this trend continue to rise.</p><h4><strong>3. Big market potential</strong></h4><p>There’s a significant market valued at $200 million AUD in Australia. A <a href="http://mgcpharma.com.au/wp-content/uploads/2016/03/mgc_whitepaper_final-sml.pdf">white paper</a> developed by MGC Pharma and the University of Sydney found that there would be a patient portfolio of around 30,000 Australians with HIV, epilepsy and MS that would seek to use Medical Cannabis for treatment in the future.</p><h4><strong>4. You’re part of a movement</strong></h4><p>There’s been a negative stigma surrounding Medical Cannabis for decades. Fortunately there were people that recognised the benefits and how it can effectively treat children who suffer from <a href="http://www.abc.net.au/news/2017-05-25/scientific-study-medicinal-cannabis-helps-children-with-epilepsy/8556180">severe epilepsy</a>, people with <a href="http://www.smh.com.au/nsw/medicinal-cannabis-study-finds-australians-suffering-chronic-pain-get-more-relief-from-cannabis-than-conventional-medicines-20150126-12y52e.html">chronic pain</a> and many other diseases. Now that the effects of Medical Cannabis have been recognised by a wider community and it has been legalised in countries across the world, it’s the perfect time to join the movement and help improve the lives of patients around the world.</p><p><strong>Did you know?</strong></p><p>MGC Pharmaceuticals Ltd (ASX: MXC) is a global specialist Medical Grade Cannabis company with many years of technical, clinical and commercial experience in the industry. The Company’s founders are all key figures in the Israeli Medical Cannabis industry. MGC Pharma’s core business strategy is to develop and supply high quality Cannabinoid based pharmaceutical products for the growing Medical markets in Europe, North America and Australasia.</p><p>We have a diverse range of leaders at MGC Pharmaceuticals, all with a wealth of experience and a dedication to health and bringing Medical Cannabis to the forefront of Medical research and innovation.</p><p>We believe that Medical Cannabis will effectively treat previously unmet medical needs and improve the lives of patients, impacting public health across the world.</p><p>MGC embraces this by creating pharmaceutical grade products and providing them in various markets. These products are registered for sale and leverage the Company’s own proprietary Medical Cannabis formula through clinical trials in Europe, Israel and Australia. In addition, tertiary and supplementary revenue streams solidify our presence in the market.</p><p>This enables future Medical product sales across the European Union, Australia and other geographies, following the requisite legal and regulatory approvals.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=f0ca94ac479c" width="1" height="1" alt=""><hr><p><a href="https://medium.com/mgc-pharmaceuticals/4-reasons-why-now-is-the-perfect-time-to-invest-in-the-medical-cannabis-market-f0ca94ac479c">4 reasons why now is the perfect time to invest in the Medical Cannabis Market</a> was originally published in <a href="https://medium.com/mgc-pharmaceuticals">MGC Pharmaceuticals</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
    </channel>
</rss>